News

Colorectal cancer (CRC) is the third most frequent cancer diagnosed in the world, and the second most frequent cause of death related to cancer. Imaging has a critical role in diagnosis, determining stage of the disease, selecting treatment strategies, and…   Read More

Medical imaging is pivotal in clinical trials for gastric cancer, where precise staging and response evaluation are essential. Imaging technologies like CT, MRI, and PET are integrated into clinical trials, typically using Response Evaluation Criteria in Solid Tumors (RECIST). These…   Read More

The assessment of peritoneal metastasis in ovarian cancer is a critical challenge in clinical trials. Inaccurate evaluations can lead to significant discrepancies in treatment responses and patient management. Recent discussions, including insights from Dr. M. Sharma and colleagues at ECR25,…   Read More

In the rapidly evolving landscape of clinical trials, maintaining data integrity and minimizing bias while performing BICR (Blinded Independent Central Review) is paramount. The automation of reviewer performance monitoring through advanced platforms, complemented by artificial intelligence (AI), is revolutionizing the…   Read More

Prostate cancer is a significant health concern for men, being the most prevalent non-dermatologic cancer and the second leading cause of cancer-related deaths. Advances in imaging, particularly positron emission tomography (PET), along with radioligand therapy (RLT) using specific tracers, are…   Read More

Imaging plays a crucial role in pancreatic cancer clinical trials, particularly in the early diagnosis, monitoring, and treatment response evaluation. Often referred to as the "Silent Killer," it is a highly aggressive malignancy that often presents asymptomatically in its early…   Read More

Cervical cancer is a significant global health challenge, with over half a million new cases diagnosed annually. Ranking as the fourth most common cancer among women worldwide, its early detection and accurate staging are crucial. Magnetic resonance imaging (MRI) plays…   Read More

Chronic lymphocytic leukemia (CLL) is the most prevalent form of leukemia in adults, typically affecting those aged 65 years and older. While radiologic imaging is not considered as critical for initial diagnosis or during staging, it plays a crucial role…   Read More

At Clinical Endpoints, we are a Site Management Organization (SMO) that is dedicated to revolutionizing neurology research to enhance the lives of individuals with neurological disorders. Our focus spans various conditions, including Alzheimer’s and Parkinson’s disease, as we seek innovative…   Read More

Imaging is essential in hepatocellular carcinoma (HCC) clinical trials, guiding diagnosis and monitoring treatment efficacy. Among the most valuable tools are triphasic CT and/or MRI, which significantly improve diagnostic accuracy by differentiating liver tumors from surrounding tissues and assessing treatment…   Read More